E. F. Winton

693 total citations
14 papers, 481 citations indexed

About

E. F. Winton is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, E. F. Winton has authored 14 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in E. F. Winton's work include Hematopoietic Stem Cell Transplantation (5 papers), Mesenchymal stem cell research (2 papers) and Immune Cell Function and Interaction (2 papers). E. F. Winton is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Mesenchymal stem cell research (2 papers) and Immune Cell Function and Interaction (2 papers). E. F. Winton collaborates with scholars based in United States, Australia and United Kingdom. E. F. Winton's co-authors include Robert G. Tardiff, Leland J. McCabe, Elizabeth A. Grimm, Masato Yagita, WC Chan, Kathleen F. Bongiovanni, M Tsudo, C K Goldman, Thomas A. Waldmann and Bette K. Go and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

E. F. Winton

14 papers receiving 430 citations

Peers

Countries citing papers authored by E. F. Winton

Since Specialization

Citations

This map shows the geographic impact of E. F. Winton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. F. Winton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. F. Winton more than expected).

Fields of papers citing papers by E. F. Winton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. F. Winton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. F. Winton. The network helps show where E. F. Winton may publish in the future.

Co-authorship network of co-authors of E. F. Winton

This figure shows the co-authorship network connecting the top 25 collaborators of E. F. Winton. A scholar is included among the top collaborators of E. F. Winton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. F. Winton. E. F. Winton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD) 2017 ·Biology of Blood and Marrow Transplantation ·H. Jean Khoury, Vamsi Kota, Martha Arellano, Stephanie Bauer, Anand P. Jillella, Amelia Langston, Zaid Al‐Kadhimi, Zachariah DeFilipp, (unknown), E. F. Winton, John F. DiPersio	4
2	Results of COMFORT-I, a randomized double-blind phase III trial of JAK 1/2 inhibitor INCB18424 (424) versus placebo (PB) for patients with myelofibrosis (MF). 2011 ·Journal of Clinical Oncology ·Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, (unknown), Vikas Gupta, John F. DiPersio, J. Catalano, (unknown), Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. F. Winton, Jimmie H. Harvey, Kris Vaddi, Susan Erickson‐Viitanen, Iphigenia L. Koumenis, Wenjing Sun, V. Sandor, H. Kantarjian, (unknown)	25
3	Paediatric surgery: trends in UK surgical trainees' operative experience 2006 ·Journal of Pediatric Surgery ·George Youngson, Stephen Adams, E. F. Winton	6
4	High Dose Chemotherapy Without Hematopoietic Cell Support for the Treatment of Refractory Lymphoma 2000 ·Leukemia & lymphoma ·Sagar Lonial, Timothy W. Jones, S M Devine, E. F. Winton, Leonard T. Heffner, Kenneth J. Smith, (unknown), Edmund K. Waller	6
5	Platelet recovery following autologous bone marrow transplantation correlates with the content of cd34+, cd38- cells in the marrow graft 1997 ·Experimental Hematology ·Edmund K. Waller, (unknown), Michael Lynn, E. F. Winton, Robert A. Bray, (unknown), Hilary Rosenthal, (unknown), H. Kent Holland, Andrew M. Yeager	1
6	Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation 1997 ·Bone Marrow Transplantation ·(unknown), (unknown), Kevin S. O’Toole, (unknown), James W. Keller, Daniela Mauer, (unknown), S P Dix, (unknown), Istvan Redei, (unknown), (unknown), C D Hillyer, Edmund K. Waller, E. F. Winton, John R. Wingard	14
7	Vancomycin-resistant Aureobacterium species cellulitis and bacteremia in a patient with acute myelogenous leukemia 1996 ·Journal of Clinical Microbiology ·Frederick S. Nolte, Kathryn E. Arnold, (unknown), E. F. Winton, Guido Funke	14
8	Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model. 1993 ·PubMed ·Christopher D. Hillyer, R. Brent Swenson, (unknown), (unknown), E. F. Winton	17
9	Studies of an improved rhesus hematopoietic progenitor cell assay. 1992 ·PubMed ·E. F. Winton, Paulette Jacobs, (unknown), (unknown), (unknown), E. Liehl, Raphael Stoll, (unknown), H M McClure	8
10	Modulation of retinoic acid-induced differentiation of human leukemia (HL-60) cells by serum factors and sphinganine. 1990 ·PubMed ·Victoria L. Stevens, (unknown), E. F. Winton, Joseph M. Kinkade, Alfred H. Merrill	26
11	Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools. 1989 ·PubMed ·William Sheridan, (unknown), (unknown), Amanda Olson, William R. Vogler, E. F. Winton	5
12	The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. 1987 ·Proceedings of the National Academy of Sciences ·M Tsudo, C K Goldman, Kathleen F. Bongiovanni, WC Chan, E. F. Winton, Masato Yagita, Elizabeth A. Grimm, Thomas A. Waldmann	191
13	A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial 1984 ·Blood ·(unknown), E. F. Winton, (unknown), (unknown), Bette K. Go, (unknown)	77
14	NITRATE IN DRINKING WATER 1971 ·American Water Works Association ·E. F. Winton, Robert G. Tardiff, Leland J. McCabe	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact